Answers are grounded in this paper and cite their sources.
In the last decade, PCI techniques advanced, but recent trends in high-risk populations, especially prior CABG patients, lack sufficient data. This study explores current PCI outcomes in older ACS patients with a CABG history, addressing the need for tailored insights for this at-risk group. Using the 2016-2020 National Inpatient Sample database and relevant ICD-10 CM codes, we examined trends in PCI outcomes for ACS patients aged >65 with a history of CABG. Primary outcomes were measured to assess the observed trends. Among 94,610 patients, 74.5% were male and 84.1% were of white ethnicity, with a median age of 75 years. 94.6% underwent non-elective PCI. Common comorbidities included hyperlipidemia (83.7%), smoking (40%), complicated diabetes (34.6%), and hypertension (53.7%). Statistically significant variations were observed in post-catheterization-related bleeding (PC-B), post-procedural respiratory failure (PP-RF), and Impella usage post-PCI (all P<0.001). There were declining trends in PC-B (1.5% in 2016 vs. 0.7% in 2020, P<0.001) and PP-RF (0.3% in 2016 vs. 0.2% in 2020, P<0.001), with an increase in Impella usage post-PCI (1.2% in 2016 vs. 2.1% in 2020). Following PCI, no statistically significant differences were noted in outcomes such as all-cause mortality (ACM), intracranial bleed (IC-B), cardiac arrest (CA), post-procedural stroke (PP-S), cardiogenic shock, and intra-aortic balloon pump (IABP) usage. Higher-risk patients, like those with prior CABG, show improved outcomes with advanced diagnostics, therapeutics, and hemodynamic support devices, reducing mortality and morbidity trends.
No takes yet. Share an insight, caveat, or question.
Senapati et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: